Review Article
Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches
Table 5
Clinicopathological features of osetosarcoma tissue samples for prognosis study.
| | Sample name | Age | Gender | Histological subtype | Site | Huvos grading | Preoperation chemotheapy agents | Mstastasis
(months) | Followup
(months) | Status |
| | Metastasis within 2 years |
| | OS07 | 43 | Male | Osteoblastic | Pelvis | 2 | MTX, ADR/CDDP | 6 | 27 | DOD | | OS11 | 19 | Male | Osteoblastic | Distal tibia | 3 | HD-MTX, ADR/CDDP | 18 | 88 | NED | | OS16 | 67 | Female | Osteoblastic | Distal femur | — | — | 19 | 38 | DOD | | OS17 | 13 | Female | Osteoblastic | Proximal tibia | 1 | HD-MTX | 15 | 51 | DOD | | OS22 | 61 | Male | Osteoblastic | Spine | — | — | 5 | 7 | DOD | | OS26 | 19 | Male | Osteoblastic | Distal femur | 1 | HD-MTX, CDDP | 19 | 45 | AWD | | OS27 | 15 | Female | Osteoblastic | Distal femur | 3 | HD-MTX, IFO, ADR/CDDP | At diagnosis | 26 | DOD | | OS28 | 9 | Female | Osteoblastic | Proximal tibia | 4 | HD-MTX, CDDP/ADR, | 6 | 51 | NED | | OS41 | 18 | Male | Osteoblastic | Pelvis | 1 | IFO, CDDP/ADR | At diagnosis | 18 | DOD | | OS44 | 18 | Male | Osteoblastic | Distal femur | 1 | IFO/VP | At diagnosis | 3 | DOD | | OS46 | 18 | Male | Chondroblastic | Distal femur | 2 | IFO, CDDP/ADR | At diagnosis | 17 | NED | | OS47 | 14 | Male | Chondroblastic | Proximal femur | 1 | IFO, CDDP/ADR | At diagnosis | 15 | AWD |
| | No metastasis over 3 years |
| | OS18 | 14 | Male | Osteoblastic | Proximal tibia | 1 | HD-MTX, ADR/CDDP | — | 73 | NED | | OS20 | 12 | Male | Osteoblastic | Distal femur | 1 | HD-MTX, ADR/CDDP, IFO | — | 68 | NED | | OS24 | 14 | Female | Osteoblastic | Distal femur | 4 | HD-MTX, CDDP/ADR, | — | 60 | NED | | OS32 | 19 | Male | Osteoblastic | Distal femur | 1 | HD-MTX, CDDP/ADR, | — | 47 | NED | | OS35 | 19 | Female | Fibroblastic | Proximal tibia | 3 | HD-MTX, CDDP/ADR | — | 40 | NED |
|
|
